Characterization of influenza A/Fujian/411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005

Journal of Medical Virology

Volumn 80, Issue 9, 2008, Pages 1624-1630

  Pechirra, Pedro ^a   Gonçalves, Paulo ^a   Arraiolos, Ana ^a   Coelho, Anabela ^a   Rebelo de Andrade, Helena ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Antigenic sites; Influenza A; Laboratory surveillance; Molecular evolution

Indexed keywords

AMINO ACID; HEMAGGLUTININ; INFLUENZA VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; BIOLOGICAL MONITORING; GENETIC ANALYSIS; GENETIC LINKAGE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; STRUCTURAL HOMOLOGY; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS STRAIN; WINTER;

AMINO ACID SUBSTITUTION; ANTIGENS, VIRAL; EVOLUTION, MOLECULAR; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MUTATION, MISSENSE; PHYLOGENY; PORTUGAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEROTYPING;

INFLUENZA A VIRUS;

EID: 48249135651     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21258     Document Type: Article

References (21)

1. Barr IG, Komadina N, Hurt AC, Iannello P, Tomasov C, Shaw R, Durrant C, Sjogren H, Hampson AW. 2005. An influenza AH3 reassortant was epidemic in Australia and New Zeland in2003. J Med Virol 76:391-397.
2. Besselaar TG, Botha L, McAnerney JM, Schoub BD. 2004. Antigenic and molecular analysis of influenza A(H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J Med Virol 73:71-78.
3. Bush RM, Fitch WM, Bender CA, Cox NJ. 1999. Positive selection on the H3 hemagglutinin gene of human influenza. Mol Biol Evol 16:1457-1465.
4. Ellis JS, Fleming DM, Zambon MC. 1997. Multiple reverse transcription PCR for the surveillance of influenza A and B virus in England & Wales in 1995 and 1996. J Clin Microbiol 35:2076-2082.
5. Grist NR, Ross CA, Bell EJ. 1966. Diagnostic methods in clinical virology, 1st edition. Oxford: Blackwell Scientific Publishers.
6. Hungnes O. 2006. Early detection of A/Califórnia/7/2004-like A(H3N2) strains in Norway during the2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end. Vaccine 24:6694-6696.
7. Ikone N, Pyhala R, Toivonen M, Korpela H. 2006. Influenza A/Fujian/411/02(H3N2)-lineage viruses in Finland: Genetic diversity, epidemic activity and vaccination-induced antibody response. Arch Virol 151:241-254.
8. Kumar S, Tamura K, Nei M. 2004. MEGA 3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Briefings Inform 5:150-163.
9. Lu B, Zhou H, Ye D, Kemble G, Jin H. 2005. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J Virol 79:6763-6771.
10. Macken C, Lu H, Goodman J, Boykin L. 2001. The value of a database in surveillance and vaccine selection. In: Osterhaus ADME, Cox N, Hampson AW, editors. Options for the control of influenza IV. Amsterdam: Elsevier Science. pp 103-106.
11. Meijer A, Paget WJ, Meerhoff TJ, Brown CS, Meuwissen LE, van der Elden J. EISS. 2006. Epidemiological and virological assessment of influenza activity in Europe during the2004-2005 winter. Eurosurveillance 11:111-117.
12. Muñoz E, Deem M. 2005. Epitope analysis for influenza vaccine design. Vaccine 23:1144-1148.
13. Paget WJ, Meerhoff TJ, Meijer A, on behalf of EISS. 2005. Epidemiological and virological assessment of influenza activity in Europe during the 2003-2004 season. Eurosurveillance 10:107-111.
14. Pechirra P, Nunes B, Coelho A, Ribeiro C, Gonçalves P, Pedro S, Castro LC, Rebelo-de-Andrade H. 2005. Molecular characterization of the HA gene of influenza type B viruses. J Med Virol 77:541-549.
15. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
16. World Health Organisation. 2003a. Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Weekly Epidemiol Record 78:58-62.
17. World Health Organisation. 2003b. Addendum to the recommended composition of influenza virus vaccines for use in the2003-2004influenza season. Weekly Epidemiol Record 78:77.
18. World Health Organisation. 2004. Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Weekly Epidemiol Record 79:88-92.
19. World Health Organisation. 2005. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Weekly Epidemiol Record 80:71-75.
20. Widjaja L, Ilyushina N, Webster R, Webby R. 2006. Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 350:137-145.
21. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 289:373-378.